TCF7 and breast cancer: More importantly, in vitro experiments performed by the mentioned group revealed that synthetic miR159 is capable of reducing the proliferation of breast cancer cells by targeting sequence of the 3′ untranslated region (UTR) of Transcription Factor 7 (TCF7) mRNA.